Firebrick Pharma (ASX:FRE) Days Inventory : 1,289.83 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Firebrick Pharma's Average Total Inventories for the six months ended in Jun. 2024 was A$0.26 Mil. Firebrick Pharma's Cost of Goods Sold for the six months ended in Jun. 2024 was A$0.04 Mil. Hence, Firebrick Pharma's Days Inventory for the six months ended in Jun. 2024 was 1,289.83.

The historical rank and industry rank for Firebrick Pharma's Days Inventory or its related term are showing as below:

ASX:FRE' s Days Inventory Range Over the Past 10 Years
Min: 2305.26 Med: 2305.26 Max: 2579.66
Current: 2579.66

During the past 4 years, Firebrick Pharma's highest Days Inventory was 2579.66. The lowest was 2305.26. And the median was 2305.26.

ASX:FRE's Days Inventory is ranked worse than
99.68% of 945 companies
in the Drug Manufacturers industry
Industry Median: 156.81 vs ASX:FRE: 2579.66

Firebrick Pharma's Days Inventory increased from Jun. 2023 (0.00) to Jun. 2024 (1,289.83). It might indicate that Firebrick Pharma's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Firebrick Pharma's Inventory Turnover for the six months ended in Jun. 2024 was 0.14.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Firebrick Pharma Days Inventory Historical Data

The historical data trend for Firebrick Pharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Days Inventory Chart

Firebrick Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Days Inventory

2,305.26

Firebrick Pharma Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23	Jun24
Days Inventory	-	-	-	-	1,289.83

Competitive Comparison of Firebrick Pharma's Days Inventory

For the Drug Manufacturers - General subindustry, Firebrick Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Firebrick Pharma's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's Days Inventory falls into.

Firebrick Pharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Firebrick Pharma's Days Inventory for the fiscal year that ended in Jun. 2024 is calculated as

	Days Inventory (A: Jun. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Jun. 2023 )	+	Total Inventories (A: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2024 )	*	Days in Period
=	( (0	+	0.24)	/	1 )	/	0.038	*	365
=	0.24					/	0.038	*	365
=	2,305.26

Firebrick Pharma's Days Inventory for the quarter that ended in Jun. 2024 is calculated as:

	Days Inventory (Q: Jun. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2023 )	+	Total Inventories (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0.283	+	0.24)	/	2 )	/	0.037	*	365 / 2
=	0.2615					/	0.037	*	365 / 2
=	1,289.83

Firebrick Pharma (ASX:FRE) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Firebrick Pharma's Inventory Turnover for the six months ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.037	/	0.2615
	=	0.14

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Firebrick Pharma's Inventory to Revenue for the six months ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.2615	/	-1.802
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Firebrick Pharma Days Inventory Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.firebrickpharma.com

Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines